2m 2m 2m 2m 2m 2m 2m
LANTERN PHARMA (LTRN)
NASDAQ
$2.37+$0.03 (+1.28%)
Price as of Aug 21, 2026 7:30 PM EDT- $29.9MMarket Cap
- -48.12%1-Year Change
- BiotechnologyIndustry
LANTERN PHARMA (LTRN)
$2.37+$0.03 (+1.28%)
LTRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.34 | ||
Change | +$0.05 (+2.18%) | ||
Open | $2.32 | ||
High | $2.41 | ||
Low | $2.13 | ||
Previous Close | $2.29 | ||
Volume | 185,082 | ||
30-Day Average Volume | 91,318 | ||
1-Week Change | -11.70% | ||
1-Month Change | -20.41% | ||
1-Year Change | -48.12% | ||
3-Year Change | -50.21% | ||
5-Year Change | -79.51% | ||
Fundamentals | |||
Shares Outstanding | 12.8M | ||
Total Assets | $8.6M | ||
Market Cap | $29.9M | ||
Enterprise Value | $23.3M | ||
Period: QTR TTM FY | |||
Revenue | $27,238.00 | ||
Net Income | -$7.1M | ||
Free Cash Flow | -$2.9M | ||
EBIT | -$7.1M | ||
EBITDA | -$7.1M | ||
Net Working Capital | $4.1M | ||
EPS | -$0.57 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 854 | ||
P/B | N/A | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue